Detalles de la búsqueda
1.
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
Lancet Oncol
; 22(12): 1669-1680, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34741822
2.
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial.
Lancet
; 395(10232): 1268-1277, 2020 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32145825
3.
A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first-line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin.
BJU Int
; 126(2): 292-299, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32336008
4.
The value of physical performance measurements alongside assessment of sarcopenia in predicting receipt and completion of planned treatment in non-small cell lung cancer: an observational exploratory study.
Support Care Cancer
; 26(1): 119-127, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28721555
5.
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.
Lancet Oncol
; 16(1): 76-86, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25498218
6.
Personalised cancer medicine.
Int J Cancer
; 137(2): 262-6, 2015 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24789362
7.
Association of sarcopenia and observed physical performance with attainment of multidisciplinary team planned treatment in non-small cell lung cancer: an observational study protocol.
BMC Cancer
; 15: 544, 2015 Jul 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26204885
8.
Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial.
J Clin Oncol
; 42(13): 1466-1471, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38350047
9.
Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer.
Invest New Drugs
; 31(4): 1001-7, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23329066
10.
Ethnoveterinary practises of medicinal plants used for the treatment of different cattle diseases: A case study in East Khasi Hill district of Meghalaya, North East India.
Heliyon
; 9(7): e18214, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37501975
11.
Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
Cancer
; 118(16): 3920-7, 2012 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22614698
12.
Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells.
Nat Med
; 11(10): 1073-81, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16170322
13.
Precise scheduling of chemotherapy primes VEGF-producing tumors for successful systemic oncolytic virotherapy.
Mol Ther
; 19(10): 1802-12, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21792179
14.
Development of a low-seroprevalence, αvß6 integrin-selective virotherapy based on human adenovirus type 10.
Mol Ther Oncolytics
; 25: 43-56, 2022 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35399606
15.
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.
J Natl Cancer Inst
; 114(7): 979-987, 2022 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35417006
16.
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.
JAMA Oncol
; 8(1): 114-122, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34817562
17.
Efficient Intravenous Tumor Targeting Using the αvß6 Integrin-Selective Precision Virotherapy Ad5NULL-A20.
Viruses
; 13(5)2021 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34066836
18.
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry.
Ther Adv Med Oncol
; 13: 17588359211053416, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34777582
19.
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective.
Ther Adv Med Oncol
; 13: 17588359211042224, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34497669
20.
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.
Eur J Cancer
; 150: 190-202, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33932726